https://www.selleckchem.com/products/gw806742x.html Zn-air batteriesare a perspective power source for grid-storage. But, after they are discharged at1.1 to 1.2 V, large overpotential is required for their charging (usually 2.5 V). This is due to a sluggish oxygen evolution reaction (OER). Incorporating organic pollutants into the cathode electrolyte is a feasible strategy for lowering the required charging potential. In the discharge process, the related oxygen reduction reaction, hydrophobic electrocatalysts are more popular than hydrophilic ones. Here, a hydrophobic bifunctional polyoxometalate electrocatalyst is synthesized by precise structural design. It shows excellent activities in both bisphenol A degradation and oxygen reduction reactions. In bisphenol A containing electrolyte, to achieve 100 mA ⋅ cm-2 , its potential is only 1.32 V, which is 0.34 V lower than oxygen evolution reaction. In the oxygen reduction reaction, this electrocatalyst follows the four-electron mechanism. In both bisphenol A degradation and oxygen reduction reactions, it shows excellent stability. With this electrocatalyst as cathode material and bisphenol A containing KOH as electrolyte, a Zn-air battery was assembled. When "charged" at 85 mA ⋅ cm-2 , it only requires 1.98 V. Peak power density of this Zn-air battery reaches 120.5 mW ⋅ cm-2 . More importantly, in the "charge" process, bisphenol A is degraded, which achieves energy saving and pollutant removal simultaneously in one Zn-air battery.Myelodysplastic syndrome (MDS) is a neoplastic disease originating from hematopoietic stem cells. Currently, hematopoietic stem cell transplantation (HSCT) is the most effective cure, although lenalidomide, azacytidine, and decitabine have been applied to relieve symptoms of MDS. The purpose of this study was to evaluate the changes in endogenous metabolites by applying a UHPLC-MS (ultra-high-performance liquid chromatography-MS) metabolomics approach and to investigate metabolic pathways rel